Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer

Wang Lishui; Wang Ding; Zheng Guixi; Yang Yongmei; Du Lutao; Dong Zhaogang; Zhang Xin; Wang Chuanxin

首页> 外文期刊>The International journal of biological markers >Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer

【24h】

Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer

机译：血清肿瘤标志物在肺癌中的临床评价和治疗监测价值

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Tumor markers CYFRA21-1, CEA, NSE, CA125, pro-GRP and SCC are routinely used for lung cancer. However, there has been no systematic evaluation of these markers in the same cohort. The aim of this study was to evaluate the diagnostic and therapeutic monitoring value of these markers.

机译：背景：肿瘤标志物CYFRA21-1，CEA，NSE，CA125，pro-GRP和SCC通常用于肺癌。但是，在同一队列中尚未对这些标记物进行系统评价。这项研究的目的是评估这些标志物的诊断和治疗监测价值。

著录项

来源
《The International journal of biological markers》 |2016年第1期|共8页
作者
Wang Lishui; Wang Ding; Zheng Guixi; Yang Yongmei; Du Lutao; Dong Zhaogang; Zhang Xin; Wang Chuanxin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Diagnosis; Lung cancer; Therapeutic monitoring; Tumor markers;

机译：诊断;肺癌;治疗监测;肿瘤标志物;

相似文献

外文文献
中文文献
专利

1. Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer [J] . Wang Lishui, Wang Ding, Zheng Guixi, The International journal of biological markers . 2016,第1期

机译：血清肿瘤标志物在肺癌中的临床评价和治疗监测价值
2. Clinical Evaluation and Therapeutic Monitoring Value of Serum Tumor Markers in Lung Cancer [J] . Lishui Wang, Ding Wang, Guixi Zheng, The International journal of biological markers . 2016,第1期

机译：肺癌血清肿瘤标志物的临床评价和治疗监测价值
3. Clinical Evaluation and Cost-Effectiveness Analysis of Serum Tumor Markers in Lung Cancer [J] . RongWang, GuoqingWang, NanZhang, BioMed research international . 2013,第2期

机译：肺癌血清肿瘤标志物的临床评价和成本效果分析
4. Application of the new evaluation methods in cancer diagnosis based on serum tumor markers data [C] . Gang Wang, Ming-Cheng Li 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：基于血清肿瘤标志物数据的新评估方法在癌症诊断中的应用
5. FACT is an accelerator of tumorigenesis, a marker of aggressive, undifferentiated cancers, and a potential therapeutic target. [D] . Garcia, Henry Alexander. 2014

机译：FACT是肿瘤发生的促进剂，侵袭性，未分化癌症的标志物和潜在的治疗靶标。
6. Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China [O] . Muhammad Abbas, Said Abasse Kassim, Murad Habib, 2020

机译：患有姑息治疗的晚期非小细胞肺癌患者血清肿瘤标志物的临床评价
7. Clinical Evaluation and Therapeutic Monitoring Value of Serum Tumor Markers in Lung Cancer [O] . Lishui Wang, Ding Wang, Guixi Zheng, 2016

机译：肺癌血清肿瘤标志物的临床评价与治疗监测价值
8. Tumor Marker CA 125: The Clinical Significance of the Serum Marker CA 125 in the Management of Patients with Ovarian Cancer [R] . van der Burg, M. E. L. 1989

机译：肿瘤标志物Ca 125：血清标志物Ca 125在卵巢癌患者管理中的临床意义

Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅